The Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trials (ALCHEMIST): Questions and Answers
ALCHEMIST represents three integrated, precision medicine trials that are designed to identify people with early-stage lung cancer who have tumors that harbor certain uncommon genetic changes and evaluate whether drug treatments targeted against those mol
Media Type: Html
- SourceUrl: https://www.cancer.gov/publishedcontent/syndication/1085893.htm
- Syndication ID: 16708
- Language: English
- Source: National Cancer Institute (NCI)
- Date Syndication Captured: Monday, May 22, 2017 at 09:10 PM
- Date Syndication Updated: Friday, March 15, 2019 at 06:05 AM
TagsPreview 0 Users liked this content.
Embed Code Snippet
To get the embed code snippet please Login.